Artículos por temáticas

Neurological complications of SARS-CoV-2: A single-center case series authors

Hassan M, Khan NU, Iqbal M, Jan Z, Rajput HM, Dewey RS, Badshah M.

Brain Hemorrhages. 2021 Dec;2(4):161-164. doi: 10.1016/j.hest.2021.09.004. Epub 2021 Sep 16.

Converging evidence in support of omega-3 polyunsaturated fatty acids as a potential therapy for Huntington's disease symptoms

Vega OM, Cepeda C.

Rev Neurosci. 2021 Apr 5;32(8):871-886. doi: 10.1515/revneuro-2021-0013. Print 2021 Dec 20.

Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration

Gudenschwager C, Chavez I, Cardenas C, Gonzalez-Billault C.

Oxid Med Cell Longev. 2021 Dec 14;2021:5586052. doi: 10.1155/2021/5586052. eCollection 2021.

Novel Substituted Heteroaryl Compounds for Treating Huntington's Disease

Sabnis RW.

ACS Med Chem Lett. 2021 Nov 15;12(12):1881-1882. doi: 10.1021/acsmedchemlett.1c00607. eCollection 2021 Dec 9.

Case Report: HSV-2 Encephalitis Presenting With Chorea; Effects of Infection Alone or Combination of Infection and Autoimmunity?

Kolesnik M, Ballout AA, Hameed N, Najjar S.

Front Neurol. 2021 Dec 10;12:790514. doi: 10.3389/fneur.2021.790514. eCollection 2021.

Hyperglycemic chorea

Sasaki T, Suzuki Y, Sato M.

Oxf Med Case Reports. 2021 Dec 11;2021(11):omab118. doi: 10.1093/omcr/omab118. eCollection 2021 Nov.

Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives

Vázquez-Mojena Y, León-Arcia K, González-Zaldivar Y, Rodríguez-Labrada R, Velázquez-Pérez L.

Mov Disord. 2021 Dec;36(12):2731-2744. doi: 10.1002/mds.28819. Epub 2021 Oct 10.

Glia: A major player in glutamate-GABA dysregulation-mediated neurodegeneration

Sood A, Preeti K, Fernandes V, Khatri DK, Singh SB.

J Neurosci Res. 2021 Dec;99(12):3148-3189. doi: 10.1002/jnr.24977. Epub 2021 Nov 8.

Interweaving of Reactive Oxygen Species and Major Neurological and Psychiatric Disorders

Umare MD, Wankhede NL, Bajaj KK, Trivedi RV, Taksande BG, Umekar MJ, Mahore JG, Kale MB.

Ann Pharm Fr. 2021 Dec 9:S0003-4509(21)00175-9. doi: 10.1016/j.pharma.2021.11.004. Online ahead of print.

Exploring the Role of Orexinergic Neurons in Parkinson's Disease

Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S.

Neurotox Res. 2021 Dec;39(6):2141-2153. doi: 10.1007/s12640-021-00411-4. Epub 2021 Sep 8.

Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological induction

Ciccone L, Nencetti S, Socci S, Orlandini E.

Neural Regen Res. 2021 Dec;16(12):2353-2358. doi: 10.4103/1673-5374.300981.

Repurposing Vorinostat for the Treatment of Disorders Affecting Brain

Athira KV, Sadanandan P, Chakravarty S.

Neuromolecular Med. 2021 Dec;23(4):449-465. doi: 10.1007/s12017-021-08660-4. Epub 2021 May 4.

Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies

Domin H.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110349. doi: 10.1016/j.pnpbp.2021.110349. Epub 2021 May 13.

Cooperation of cell adhesion and autophagy in the brain: Functional roles in development and neurodegenerative disease

Hernandez SJ, Fote G, Reyes-Ortiz AM, Steffan JS, Thompson LM.

Matrix Biol Plus. 2021 Oct 23;12:100089. doi: 10.1016/j.mbplus.2021.100089. eCollection 2021 Dec.

Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?

Ostapiuk A, Urbanska EM.

CNS Neurosci Ther. 2022 Jan;28(1):19-35. doi: 10.1111/cns.13768. Epub 2021 Dec 3.